Adverse Events Tied to Exosome Therapy in Nebraska

An article published in December 2019 by MedPage Today reported that several individuals developed severe infections after receiving a placental derived exosome product in Nebraska. The Department of Health and Human Services (DHHS) stated that less than five patients became seriously ill and some developed sepsis. Specific details including the name of the product, source of donor placental tissue, and the specific bacteria that caused the infections were not released by DHHS. At this time the DHHS of Nebraska continues to investigate these reports.

Read the full article here.